排序方式: 共有24条查询结果,搜索用时 15 毫秒
1.
目的针对维持性肾脏替代治疗患者左心室功能情况及相关因素进行分析。方法将264例患者按不同肾脏替代治疗方式分为血液透析组(A组)和腹膜透析组(B组),并常规检测血肌酐(SCr)、尿素氮(BUN)、血浆白蛋白(Alb)、血红蛋白(Hb)、血钙、血磷、血总胆固醇(TC)、甘油三酯(TG)、高密度脂蛋白胆固醇(HDL-C)、低密度脂蛋白胆固醇(LDL-C)、血全段甲状旁腺激素(iPTH),超敏C反应蛋白(hs-CRP);高压液相方法检测血浆同型半胱氨酸(Hey);利用超声心动检查评价左心室功能。结果2组中,A组Hb、TG高于B组(P〈0.05),而BUN低于B组(P〈0.05);B组左心室舒张功能异常发生率高于A组(P〈0.01);A组室间隔厚度、后壁厚度低于B组,而左室舒张末内径、左室收缩末内径及舒张早期和舒张晚期二尖瓣121最大血流速度之比(E/A)及射血分数(EF)高于B组,但只有舒张早期和舒张晚期二尖瓣口最大血流速度之比(E/A)有统计学差异(P〈0.01);多因素Logistic回归分析显示,Alb、尿酸(UA)、hs—CRP、血钙、血磷水平是。肾脏替代治疗患者左室收缩功能障碍的危险因素;而年龄及收缩压与舒张压是其患者左室舒张功能障碍的危险因素。结论不同肾脏替代治疗方式下,患者左心室舒张功能异常发生率存在差异,纠正低蛋白血症,增加透析剂量,控制血压,减轻心脏负荷,纠正钙磷水平可能有助于改善其患者左心室功能异常。 相似文献
2.
目的:通过中药内服配合灌肠,观察对结直肠癌术后化疗减毒增效的作用,为提高结直肠癌患者的生存质量提供更有效的方法。方法:将结直肠癌根治术后患者60例,随机分为两组,每组30例,治疗组在化疗药物基础上加用中药内服和保留灌肠,对照组单纯用化疗药物,4周为1疗程,观察两组化疗引起的主要临床症状、KPS评分、血细胞、T细胞亚群的变化情况。结果:治疗组化疗引起的主要症状发生率明显低于对照组;治疗组体力状况较前改善,对照组体力状况较前下降;组间比较,治疗组的体力状况明显优于对照组;两组病例不同时间WBC和PLT均有不同程度下降,第2、3周治疗组降低程度小于对照组;治疗组的免疫力强于对照组。结论:中药可以减轻结直肠癌术后化疗患者的毒副反应、改善患者的临床症状,提高生活质量及肌体免疫功能。 相似文献
3.
目的对维持性血液透析患者左心室收缩功能情况及相关因素进行分析。方法回顾性分析我院肾脏病血液净化科2007~2009年收治的维持性血液透析治疗患者196例临床资料,选取同期门诊健康查体者80例作为对照。结果维持性血液透析组左室舒张末内径、射血分数、室间隔厚度、后壁厚度、左室收缩末内径及舒张早期和舒张晚期二尖瓣口最大血流速度之比均高于对照组,P〈0.01;多因素Logistic回归分析显示,血浆白蛋白、肌酐水平是维持性血液透析患者左室收缩功能障碍的危险因素(P〈0.叭或〈0.05)。结论维持性血液透析治疗患者存在左心室收缩功能障碍,积极纠正低蛋白血症、增加透析剂量、减轻心脏负荷可能有助于改善左心室收缩功能。 相似文献
4.
5.
Objective To explore the value of combined echocardiography and brain natriuretic peptide (BNP) levels in acute pulmonary embolism (APE) treated by thrombolysis.Methods Echocardiography,pulmonary ventilation-perfusion imaging and plasma BNP levels were performed before thrombolysis and 24 - 48 h after thrombolysis in 31 patients with diagnosis of APE and signs of right ventricular pressure overload.Results Twenty-six patients with thrombolysis effective,after thrombolysis,the pulmonary artery systolic pressure decreased from (57.3 ± 18.2)mm Hg to (40.4 ± 15.4)mm Hg (P= 0.003) ,the right ventricular diastolic diameter reduced from (40.6 ± 6.1)mm to (35.4 ± 6.0)mm (P <0.01) ,the pulmonary artery diameter reduced from (27.2 ± 4.9)mm to (22.5 ± 4.4)mm (P = 0.004) ,the left ventricular diastolic diameter increased from (42.4 ± 7.2)mm to (43.1 ± 6.9)mm (P = 0.42),septal contradiction were reduced from 20 cases to 10 cases (P = 0.02),plasma BNP levels decreased from (278.8 ± 43.3)ng/L to (119.1 ± 40.4)ng/L (P = 0.000 01).Five patients with thrombolysis ineffective,there were no significant changes before and after thrombolytic therapy in the parameters of echocardiography,however,plasma BNP levels increased from (431.8 ± 57.7) ng/L to (496.4 ± 70.3) ng/L(P = 0.03).Plasma BNP levels and pulmonary artery systolic pressure had a better relationship(r = 0.62,P <0.01).Conclusions The pulmonary perfusion and right ventricular function in patients with APE can be rapidly improved by thrombolytic therapy.Combined echocardiography and the BNP levels is a sensitive index in the hemodynamic changes of thrombolytic therapy,and can evaluate the treatment accurately. 相似文献
6.
7.
丹红注射液对单侧输尿管梗阻大鼠肾间质纤维化的影响及机制 总被引:2,自引:1,他引:1
目的 观察中药丹红注射液对单侧输尿管梗阻(UUO)大鼠.肾小管上皮细胞转分化(EMT)和间质炎症细胞浸润的影响及机制.方法 SD大鼠60只,随机分为假手术(A组)、UUO(B组)、厄贝沙坦[50 mg/(kg·d),灌胃,C组]和丹红注射液治疗组[7 mL/(kg·d),腹腔注射,D组1.3、7和14 d留取标本.结果 ①B组各时间点分化抑制因子1(Idl)mRNA和蛋白、α-SMA、NF κ B和Ⅰ型胶原表达增多,上皮细胞钙黏蛋白(E-cad)表达逐渐减少(均P<0.05).D组各时问点均反相调节上述因子表达;疗效与C组相似.②B组大量CD68+细胞流入肾间质,调节正常T细胞表达和分泌因子(RANTES)mRNA和蛋白及巨噬细胞集落刺激因子(M-CSF)表达明显上调,D组下调其表达及炎症细胞浸润,作用弱于C组(均P<0.05).结论 丹红注射液可通过抑制EMT和肾间质炎症细胞浸润,减轻肾间质纤维化. 相似文献
8.
目的 观察丹红注射液对单侧输尿管梗阻(UUO)大鼠逆转录病毒E26转录因子1(Ets-1),基质金属蛋白酶9(MMP-9)和金属蛋白酶组织抑制因子-1(TIMP-1)表达的影响,初步探讨其抗肾间质纤维化的作用机制.方法 SD大鼠60只,随机分为假手术(A组),UUO(B组),厄贝沙坦[C组,50mg/(kg·d),灌胃]和丹红注射液治疗组[D组,7 mg/(kg·d),腹腔注射].手术后3、7及14d留取标本.RT-PCR测Ets-1 mRNA含量;免疫组织化学法测Ets-1、MMP-9、TIMP-1及TGF-β1和I型胶原表达.结果 D组肾间质纤维化面积和I型胶原表达明显低于B组(P<0.05).D组7d Ete-1 Mrna 表达量达峰值并明显高于B组,B组术后3d Ets-1表达开始升高,7d到达峰值,14d开始下降,与MMP-9的趋势一致.Ets-1与MMP-9和MMP-9/TIMP-1比值正相关(r=0.711和0.635,P=0.001和0.005).D组各时间点下调TIMP-1表达(P<0.05),TIMP-1与TGF-β1和I型胶原正相关(r=0.831和0.478,P=0.000和0.045).结论 丹红注射液上调Ets-1表达促进细胞外基质降解而减轻肾间质纤维化. 相似文献
9.
目的对老年肾替代治疗患者左心室功能异常的情况及相关因素进行分析。方法选取天津医科大学第二医院肾脏病血液净化科2007~2009年收治的老年肾替代治疗患者100例,按肾替代治疗方式分为血液透析组和腹膜透析组;同时选取同期健康查体老年人80例作为对照。对所有患者均常规检测血清肌酐、尿素氮、白蛋白、血红蛋白、血钙、血磷、血清胆固醇(TC)、甘油三酯(TG)、高密度脂蛋白-胆固醇(HDL-C)、低密度脂蛋白-胆固醇(LDL-C)、血全段甲状旁腺激素(i-PTH);高压液相方法检测血浆同型半胱氨酸;利用超声心动检查评价左心室功能。结果两组老年肾替代治疗患者血红蛋白水平存在差异,老年血液透析组患者高于老年腹膜透析组,其余生化指标无统计学意义;两组老年肾替代治疗患者左心室功能异常发生率差异无统计学意义,但后壁厚度差异具有统计学意义,腹膜透析组患者高于血液透析组;与健康查体老年对照组相比,老年肾替代治疗组各项左心功能指标与健康查体老年对照组相比差异均具有统计学意义(P<0.01或P<0.05)。多因素Logistic回归分析显示,血浆白蛋白水平是老年肾替代治疗患者左心室收缩功能障碍的危险因素。结论不同肾替代治疗方式下,老年肾替代治疗患者左心室功能异常发生率无差异,纠正低蛋白血症,增加透析剂量,减轻心脏负荷可能有助于改善左心室收缩功能。 相似文献
10.
目的 探讨超声心动图联合血浆脑钠肽(brain natriuretic peptide,BNP)检测在急性肺栓塞(acute pulmonary embolism,APE)溶栓治疗中的价值.方法 确诊APE且超声提示有右心压力超负荷征象患者31例进行溶栓治疗,分别在溶栓前和溶栓后24~48 h行超声、肺通气-灌注显像检查及BNP检测.结果 26例溶栓有效,溶栓后其肺动脉收缩压由(57.3±18.2)mm Hg降至(40.4±15.4)mm Hg(P=0.003),右室舒张末径由(40.6±6.1)mm减小为(35.4±6.0)mm(P<0.01),肺动脉内径由(27.2±4.9)mm减小为(22.5±4.4)mm(P=0.004),左室舒张末径由(42.4±7.2)mm增加为(43.1±6.9)mm(P=0.42),室间隔矛盾运动者由20例减少为10例,血浆BNP由(278.8±43.3)ng/L下降为(119.1±40.4)ng/L(P=0.000 01).5例溶栓无效,溶栓前后超声心动图各参数无明显变化,但血浆BNP由(431.8±57.7)ng/L增加为(496.4±70.3)ng/L(P=0.03).血浆BNP水平与肺动脉收缩压有较好相关关系(r=0.62,P<0.01).结论 溶栓治疗能迅速改善APE患者的肺灌注和右心功能.超声联合BNP水平检测可敏感地反映溶栓治疗中的血流动力学变化,准确评价疗效.Abstract: Objective To explore the value of combined echocardiography and brain natriuretic peptide (BNP) levels in acute pulmonary embolism (APE) treated by thrombolysis.Methods Echocardiography,pulmonary ventilation-perfusion imaging and plasma BNP levels were performed before thrombolysis and 24 - 48 h after thrombolysis in 31 patients with diagnosis of APE and signs of right ventricular pressure overload.Results Twenty-six patients with thrombolysis effective,after thrombolysis,the pulmonary artery systolic pressure decreased from (57.3 ± 18.2)mm Hg to (40.4 ± 15.4)mm Hg (P= 0.003) ,the right ventricular diastolic diameter reduced from (40.6 ± 6.1)mm to (35.4 ± 6.0)mm (P <0.01) ,the pulmonary artery diameter reduced from (27.2 ± 4.9)mm to (22.5 ± 4.4)mm (P = 0.004) ,the left ventricular diastolic diameter increased from (42.4 ± 7.2)mm to (43.1 ± 6.9)mm (P = 0.42),septal contradiction were reduced from 20 cases to 10 cases (P = 0.02),plasma BNP levels decreased from (278.8 ± 43.3)ng/L to (119.1 ± 40.4)ng/L (P = 0.000 01).Five patients with thrombolysis ineffective,there were no significant changes before and after thrombolytic therapy in the parameters of echocardiography,however,plasma BNP levels increased from (431.8 ± 57.7) ng/L to (496.4 ± 70.3) ng/L(P = 0.03).Plasma BNP levels and pulmonary artery systolic pressure had a better relationship(r = 0.62,P <0.01).Conclusions The pulmonary perfusion and right ventricular function in patients with APE can be rapidly improved by thrombolytic therapy.Combined echocardiography and the BNP levels is a sensitive index in the hemodynamic changes of thrombolytic therapy,and can evaluate the treatment accurately. 相似文献